Skip to content
Search

Latest Stories

Covid-19 lockdown having an effect: Study  

Data gathered from two million people in Britain using a new Covid-19 symptom tracker app suggests lockdown measures are slowing the spread of the disease, researchers said on Wednesday (8).

The rate of new coronavirus symptoms reported in Britain has slowed significantly in the past few days, the King’s College London scientists said.


Their latest figures suggest that around 1.4 million people in Britain aged between 20 and 69 currently have symptomatic Covid-19, a fall from 1.9 million on April 1, as some have recovered and fewer people report new symptoms.

The drop in new symptoms suggests that although the numbers of Covid-19 patients being admitted to hospital are rising, as are the numbers dying, these should start to fall in about two weeks if social distancing measures are kept in place.

Official figures show Britain's total hospital deaths from Covid-19 rose by 786 to 6,159 as of 1600 GMT on Monday (6).

Like many other countries hit by the pandemic, Britain has imposed strict social distancing along with shop and school closures. Introducing the measures more than two weeks ago, authorities also asked everyone to stay at home except for essential travel.

Tim Spector, who led the King's team analysing the symptom tracker data, said the signs were "encouraging".

"Even though hospital admissions and deaths are still on the rise, we hope that these figures offer a much needed light at the end of the tunnel," he said.

Spector's analysis comes after preliminary work by researchers at the London School of Hygiene and Tropical Medicine published a week ago also showed that social distancing may already be working by dramatically reducing the number of daily contacts between people.

Spector said his data showed, however, that Britain's larger cities like London, Birmingham, Glasgow and Liverpool "continue to have very high levels of symptoms in the community".

London Mayor Sadiq Khan said on Wednesday that Britain is in no position to ease the shutdown as the peak of the Covid -19 outbreak is still likely to be more than a week away.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less